|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Indian medicinal herbs as sources of antioxidants显示文摘 | Shahin Sharif Ali Naresh Kasoju Abhinav Luthra Angad Singh Hallihosur Sharanabasava Abhishek Sahu Utpal Bora | 2007 | Food Research International2007，，1： | 4 |
| 2 | Indian medicinal herbs as sources of antioxidants显示文摘 | Shahin Sharif Ali Naresh Kasoju Abhinav Luthra Angad Singh Hallihosur Sharanabasava Abhishek Sahu Utpal Bora | 2007 | Food Research International2007，，1： | 1 |
| 3 | Artificial intelligence based optimization of exocellular glucansucrase production from Leuconostoc dextranicum NRRL B-1146显示文摘 | SINGH ANGAD MAJUMDER AVISHEK GOYAL ARUN | 2008 | Bioresource Technology2008，99，17： | 1 |
| 4 | Application of responsesurface methodology for glucan productionfrom Leuconostoc dex -tranicum and its structural characterization显示文摘 | Avishek Majumder Angad Singh Arun Goyal | 2009 | Carbohydrate Poly-mers2009，75，： | 1 |
| 5 | Liver transplant in primary sclerosing cholangitis:Current trends and future directions显示文摘Primary sclerosing cholangitis(PSC)is a chronic and progressive immunemediated cholangiopathy causing biliary tree inflammation and scarring,leading to liver cirrhosis and end-stage liver disease.Diagnosis of PSC is challenging due to its nonspecific symptoms and overlap with other liver diseases.Despite the rising incidence of PSC,there is no proven medical therapy that can alter the natural history of the disease.While liver transplantation(LT)is the most effective approach for managing advanced liver disease caused by PSC,post-transplantation recurrence of PSC remains a challenge.Therefore,ongoing research aims to develop better therapies for PSC,and continued efforts are necessary to improve outcomes for patients with PSC.This article provides an overview of PSC’s pathogenesis,clinical presentation,and management options,including LT trends and future aspects.It also highlights the need for improved therapeutic options and ethical considerations in providing equitable access to LT for patients with PSC.Additionally,the impact of liver transplant on the quality of life and psychological outcomes of patients with PSC is discussed.Ongoing research into PSC’s pathogenesis and post-transplant recurrence is crucial for improved understanding of the disease and more effective treatment options. | Yash R Shah Natalia Nombera-Aznaran David Guevara-Lazo Ernesto Calderon-Martinez Angad Tiwari SriLakshmiDevi Kanumilli Purva Shah Bhanu Siva Mohan Pinnam Hassam Ali Dushyant Singh Dahiya | 2023 | World Journal of Hepatology2023，15，8： | 0 |
| 6 | 如何设计可靠的电力线通信显示文摘电力线通信(PLC)是一种采用电力线作为通讯介质的通信技术。在与供电作用的同一根电力线上传输数据,从而可以将房屋或汽车现有的电力基础设施用于传输数据,而不需要新加电线。电力线通信技术正在经历快速增长的阶段,并找到了进入多个应用和市场领域的方式,包括智能电网、照明控制、太阳能面板监控、能量计量、家用视频分配、电动汽车等等。并能克服通常的设计挑战。 | Ashish Garg Angad Singh Gill | 2011 | 电子设计技术 EDN CHINA2011，18，8： | 0 |
| 7 | Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions显示文摘Fecal microbiota transplantation(FMT)offers a potential treatment avenue for hepatic encephalopathy(HE)by leveraging beneficial bacterial displacement to restore a balanced gut microbiome.The prevalence of HE varies with liver disease severity and comorbidities.HE pathogenesis involves ammonia toxicity,gut-brain communication disruption,and inflammation.FMT aims to restore gut microbiota balance,addressing these factors.FMT's efficacy has been explored in various conditions,including HE.Studies suggest that FMT can modulate gut microbiota,reduce ammonia levels,and alleviate inflammation.FMT has shown promise in alcohol-associated,hepatitis B and C-associated,and non-alcoholic fatty liver disease.Benefits include improved liver function,cognitive function,and the slowing of disease progression.However,larger,controlled studies are needed to validate its effectiveness in these contexts.Studies have shown cognitive improvements through FMT,with potential benefits in cirrhotic patients.Notably,trials have demonstrated reduced serious adverse events and cognitive enhancements in FMT arms compared to the standard of care.Although evidence is promising,challenges remain:Limited patient numbers,varied dosages,administration routes,and donor profiles.Further large-scale,controlled trials are essential to establish standardized guidelines and ensure FMT's clinical applications and efficacy.While FMT holds potential for HE management,ongoing research is needed to address these challenges,optimize protocols,and expand its availability as a therapeutic option for diverse hepatic conditions. | Yash R Shah Hassam Ali Angad Tiwari David Guevara-Lazo Natalia Nombera-Aznaran Bhanu Siva Mohan Pinnam Manesh Kumar Gangwani Harishankar Gopakumar Amir H Sohail SriLakshmiDevi Kanumilli Ernesto Calderon-Martinez Geetha Krishnamoorthy Nimish Thakral Dushyant Singh Dahiya | 2024 | World Journal of Hepatology2024，16，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员